Angiotech Pharmaceuticals (Vancouver, British Columbia), a specialty pharmaceutical company focusing on drug-coated medical devices and biomaterials, said it has licensed a portfolio of biomaterial, drug delivery and medical device technologies from Poly-Med (Anderson, South Carolina).

Agreements

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR